InvestorsHub Logo
Followers 7
Posts 6049
Boards Moderated 0
Alias Born 06/27/2018

Re: None

Tuesday, 01/23/2024 7:25:00 PM

Tuesday, January 23, 2024 7:25:00 PM

Post# of 13962
I highly doubt that Bruce. Ora is a clinical consultant agency that focuses on helping companies through clinical trials and drug development. I believe it said that they focus on Opthamology drugs but I’m sure they do other drugs as well. Who knows. I sure don’t. Have they had this Ora company as a consultant, possibly. So many of those middle men operations around. Dime a dozen. Helps to have those type of guys when you’re going through reorganization as well. Don’t put too much thought into Satellos. Us Longs won’t know anything until they announce the definitive agreement. That’s if they announce anything. I’m merely guessing on Satellos because of the remaining indication they have. If I was Astra. I wouldn’t allow anyone to have Bert. I would want all indications. ESHA is still good in my mind. Cytovia needs another 100 million to help with the clinical studies. Any ways. That’s my two bits for today. Today’s announcement basically just puts more steam in the pot and possibly gives more credibility to the INVO merger. I still don’t believe they’ll list or do anything that brings us liquidity. They don’t need to show continuity of business enterprise. This new Florida nominal shell company giving Naya a shit drug for 4 plus million shares is a huge scam. Lucky guy. Must be a good buddy of Teper. It’s drug is unproven at best. To me, Teper is just giving us more and more of the same old fluff. It is what it is. Hula Hula Cuckoo Penny
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.